Pyrazole/pyrimidine derivatives endowed with azobenzenes as dual EGFR<sup>T790M</sup> and VEGFR-2 inhibitors: anticancer, docking, synthesis, design and ADMET assessments. [PDF]
Anwer KE +8 more
europepmc +1 more source
Synthesis, biological evaluation, molecular docking, molecular dynamics simulation, and ADME studies of novel carbazole-aniline hybrids as cytotoxic agents. [PDF]
Moradimehrabadi M +7 more
europepmc +1 more source
Pyrazolo[3,4-<i>d</i>]pyrimidine derivatives as VEGFR-2 and EGFR<sup>T790M</sup> dual inhibitors: design, docking, ADMET, synthesis and anticancer evaluations. [PDF]
Aziz NAAM +4 more
europepmc +1 more source
CRISPR-Cas9 Screening Identifies Resistance Mechanisms to KRAS Inhibition in Pancreatic Cancer. [PDF]
Long SA +24 more
europepmc +1 more source
Clinical and Molecular Characterization of a Rare EGFR cis Compound L833V/H835L Mutation in Non-Small Cell Lung Cancer. [PDF]
Jeon YH +8 more
europepmc +1 more source
In Silico Development of Novel Quinazoline-Based EGFR Inhibitors via 3D-QSAR, Docking, ADMET, and Molecular Dynamics. [PDF]
Moussaoui M +10 more
europepmc +1 more source
Synthesis and anti-cancer activity of naphthalimide-organylselanyl conjugates. [PDF]
Ravi R, Karuthapandi S.
europepmc +1 more source
Palliative Osimertinib Rechallenge Achieving Rapid Improvement in Leptomeningeal Carcinomatosis After Prior Osimertinib-Induced ILD. [PDF]
Nigi A, Iwamoto K, Itani H, Kondou S.
europepmc +1 more source
Protective Role of Thiamine Pyrophosphate Against Erlotinib-Induced Oxidative and Inflammatory Damage in Rat Optic Nerve. [PDF]
Karatas E +7 more
europepmc +1 more source

